Can BIO's new heartstrings-tugging ad campaign stem the tide of anti-pharma vitriol?

The biopharma industry is once again trying to move the national drug conversation beyond cost and profits--this time with an emotional ad campaign featuring patients young and old who've been given longer lives thanks to drug discoveries. Viewers might feel a few tugs on their heartstrings, but will it change their minds? Skeptics doubt it. More from FiercePharmaMarketing

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.